Home > Quotes > SVA > Press Releases

Sinovac Biotech, Ltd. Press Releases

SVA 
$3.2599
*  
0.0901
  negative  
2.69%
Get SVA Alerts
*Delayed - data as of May 23, 2013 9:43 ET 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
View:    SVA Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
05/17/2013 5:11AM - PR Newswire

Sinovac Presents at the UBS Global Healthcare Conference in May 2013
05/14/2013 6:00AM - PR Newswire

Sinovac Files Annual Report on Form 20-F
04/30/2013 7:48AM - PR Newswire

Sinovac Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results
04/18/2013 8:02AM - PR Newswire

Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
04/18/2013 7:17AM - PR Newswire

Sinovac Receives Commercial Approval in Mexico for Seasonal Flu Vaccine
04/18/2013 7:05AM - PR Newswire

Sinovac Schedules Conference Call and Webcast for Fourth Quarter and Full Year Unaudited Financial Results
04/02/2013 6:05AM - PR Newswire

Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology
03/18/2013 8:00AM - PR Newswire

New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry's Growth in 2012
03/15/2013 8:20AM - Market Wire

Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease
03/14/2013 6:37AM - PR Newswire